Mihai-Ştefan Bârhală
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mihai-Ştefan Bârhală has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bogdan Chivu
Neolife Medical Center Bucharest, 077190 Bucharest, Romania
1 shared publication - Dan Corneliu Jinga
Neolife Medical Center, 077190 Bucharest, Romania
1 shared publication - Horia-Dan Liscu
Department of Oncological Radiotherapy and Medical Imaging, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
1 shared publication - Ionuţ Dumitru
Neolife Bucharest, Ficusului 40 Boulevard, 013975 Bucharest, Romania
1 shared publication - Irina Mihaela Cazacu
Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania
1 shared publication - Sabina Sucuri
Coltea Clinical Hospital Bucharest, 030167 Bucharest, Romania
1 shared publication
Latest Publications
- Open Access
- 17 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (22) , 8123
Optimizing SRS for Brain Metastases: Understanding the Volume–Gradient Index Relationship
Background/Objectives: The goal is to provide a straightforward framework for generating SRS-SRT plans that reliably meet high-quality dosimetric standards. That posed some questions such as which plan quality metrics should be utilized to evaluate a plan, what influences plan quality metrics the most, and finally, how to best optimize plan geometry. Our work has primarily concentrated on the second question, guided by our clinical experience. Methods: A dataset for statistical analysis was compiled by retrospectively reviewing 200 individual SRS-SRT target volumes from two centers. From the gathered data, several Linear Regression models were generated to assess the variability of plan quality metrics using statistical analysis. The most important regressor in the models were revealed to be target volume (TV), followed by a flag type variable that indicates whether the plan used to treat the referenced target contained multiple targets (MT) or not. Results: Every doubling of TV lowers Gradient Index (GI) sharply (−0.55 to −0.17) while Gradient Measure (GM) increases moderately (+0.024 cm to +0.07 cm). The model explains 85% of the variation in GI (R2 = 0.85) and 84% of GM. Conclusions: In small lesions, GI seems to be a more sensitive evaluation metric for sub-CC SRS targets, compared to GM. Dose per fraction appeared to have had no significant effect. Treating multiple targets in the same plan appears to add an average of +0.19 to GI, independent of volume, while for GM by +0.027 cm.
- 17 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (22) , 8123
Open AccessOptimizing SRS for Brain Metastases: Understanding the Volume–Gradient Index Relationship
Background/Objectives: The goal is to provide a straightforward framework for generating SRS-SRT plans that reliably meet high-quality dosimetric standards. That posed some questions such as which plan quality metrics should be utilized to evaluate a plan, what influences plan quality metrics the most, and finally, how to best optimize plan geometry. Our work has primarily concentrated on the second question, guided by our clinical experience. Methods: A dataset for statistical analysis was compiled by retrospectively reviewing 200 individual SRS-SRT target volumes from two centers. From the gathered data, several Linear Regression models were generated to assess the variability of plan quality metrics using statistical analysis. The most important regressor in the models were revealed to be target volume (TV), followed by a flag type variable that indicates whether the plan used to treat the referenced target contained multiple targets (MT) or not. Results: Every doubling of TV lowers Gradient Index (GI) sharply (−0.55 to −0.17) while Gradient Measure (GM) increases moderately (+0.024 cm to +0.07 cm). The model explains 85% of the variation in GI (R2 = 0.85) and 84% of GM. Conclusions: In small lesions, GI seems to be a more sensitive evaluation metric for sub-CC SRS targets, compared to GM. Dose per fraction appeared to have had no significant effect. Treating multiple targets in the same plan appears to add an average of +0.19 to GI, independent of volume, while for GM by +0.027 cm.
- Open Access
Rectal Angiosarcoma: A Case Report Highlighting Multidisciplinary Strategies for Rare Malignancies
Background and Clinical Significance: Rectal angiosarcoma is an exceptionally rare and aggressive malignancy, comprising less than 1% of soft tissue sarcomas. This case highlights the diagnostic and therapeutic challenges posed by this disease, and the lack of established guidelines emphasizing the importance of a multidisciplinary approach. Case Presentation: A 41-year-old male firefighter, with a history of heavy smoking, presented with lower abdominal pain, rectal bleeding, and urgency. Imaging and biopsy confirmed rectal angiosarcoma, stage IIIB. The patient underwent IMRT/VMAT radiation therapy followed by laparoscopic rectal amputation with colostomy. No sign of recurrence or metastatic disease was present on follow-up imaging. Conclusions: This case underlines the importance of a personalized treatment strategy and multidisciplinary collaboration in rare malignancies. Early diagnosis and cooperation across specialties are critical for achieving the best possible outcomes.
Open AccessRectal Angiosarcoma: A Case Report Highlighting Multidisciplinary Strategies for Rare Malignancies
Background and Clinical Significance: Rectal angiosarcoma is an exceptionally rare and aggressive malignancy, comprising less than 1% of soft tissue sarcomas. This case highlights the diagnostic and therapeutic challenges posed by this disease, and the lack of established guidelines emphasizing the importance of a multidisciplinary approach. Case Presentation: A 41-year-old male firefighter, with a history of heavy smoking, presented with lower abdominal pain, rectal bleeding, and urgency. Imaging and biopsy confirmed rectal angiosarcoma, stage IIIB. The patient underwent IMRT/VMAT radiation therapy followed by laparoscopic rectal amputation with colostomy. No sign of recurrence or metastatic disease was present on follow-up imaging. Conclusions: This case underlines the importance of a personalized treatment strategy and multidisciplinary collaboration in rare malignancies. Early diagnosis and cooperation across specialties are critical for achieving the best possible outcomes.